ResMed, Inc. (RMD) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $226.44 +0.19%
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Selling, general and administrative: 128.85M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
ResMed, Inc. (NYSE: RMD) reported Q3 EPS of $0.33, $0.02 worse than the analyst estimate of $0.35. Revenue for the quarter came in at $314.8 million versus the consensus estimate of $326.32 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- ResMed (RMD:AU) (RMD) PT Raised to AUD46.80 at Macquarie
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
